Imunon Stock (NASDAQ: IMNN) stock price, news, charts, stock research, profile.
Open | $1.450 |
Close | - |
Volume / Avg. | 38.237K / 219.740K |
Day Range | 1.390 - 1.475 |
52 Wk Range | 0.480 - 2.000 |
Market Cap | $13.912M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 4.73% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Imunon (NASDAQ: IMNN) through any online brokerage.
Other companies in Imunon’s space includes: Immuron (NASDAQ:IMRN), Vaxxinity (NASDAQ:VAXX), Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN) and Monopar Therapeutics (NASDAQ:MNPR).
The latest price target for Imunon (NASDAQ: IMNN) was reported by HC Wainwright & Co. on Monday, April 1, 2024. The analyst firm set a price target for 13.00 expecting IMNN to rise to within 12 months (a possible 778.38% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Imunon (NASDAQ: IMNN) is $1.48 last updated Today at April 26, 2024 at 7:27 AM EDT.
There are no upcoming dividends for Imunon.
Imunon’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Imunon.
Imunon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.